Damodaran, Chendil
- Texas A&M Health Science Center · Pharmacology (NIH department code)
- Texas A&M Health Science Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #10,935
- Rising Star
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$948.1K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#10,935
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Damodaran, Chendil as a PI. Multi-PI records show the full award amount for context.
- 5R01ES033657-02R01Contact PIElucidating the molecular signaling of Cadmium Carcinogenesis$499.5Kaward amount
- 5R01CA257370-04R01Contact PITargeting AR and AR-Variants in Castration-Resistant Prostate CancerTexas A&M Health Science Center · Pharmacology (NIH department code)$448.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Damodaran, Chendil as a PI.
FY2023 award administered by Texas A&M Health Science Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardTexas A&M Health Science Center
- 2008$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2011$2M Cumulative Funding
- 2011Entered Top 50% NationallyRanked #9657
- 2012R01 Grant Holder
- 2015$5M Cumulative Funding
- 2022$10M Cumulative Funding